Robust transcriptome-wide discovery of RNA-binding protein binding sites with enhanced CLIP (eCLIP)
Abstract
As RNA-binding proteins (RBPs) play essential roles in cellular physiology by interacting with target RNA molecules, binding site identification by UV crosslinking and immunoprecipitation (CLIP) of ribonucleoprotein complexes is critical to understanding RBP function. However, current CLIP protocols are technically demanding and yield low-complexity libraries with high experimental failure rates. We have developed an enhanced CLIP (eCLIP) protocol that decreases requisite amplification by ~1,000-fold, decreasing discarded PCR duplicate reads by ~60% while maintaining single-nucleotide binding resolution. By simplifying the generation of paired IgG and size-matched input controls, eCLIP improves specificity in the discovery of authentic binding sites. We generated 102 eCLIP experiments for 73 diverse RBPs in HepG2 and K562 cells (available at https://www.encodeproject.org), demonstrating that eCLIP enables large-scale and robust profiling, with amplification and sample requirements similar to those of ChIP-seq. eCLIP enables integrative analysis of diverse RBPs to reveal factor-specific profiles, common artifacts for CLIP and RNA-centric perspectives on RBP activity.
Additional Information
© 2016 Macmillan Publishers Limited. Received 10 November 2015. Accepted 16 February 2016. Published online 28 March 2016. The authors would like to thank members of the Yeo lab (particularly S. Aigner and S. Markmiller) as well as colleagues J. Van Nostrand, Y. Kobayashi, B.R. Graveley and C.B. Burge for critical reading of the manuscript, and M. Blanco with early method development. This work was supported by grants from the US National Institutes of Health (HG004659, U54HG007005 and NS075449 to G.W.Y.), and by the US National Institutes of Health Director's Early Independence Award (DP5OD012190) and funds from the California Institute of Technology to M.G. We would also like to thank Ionis Pharmaceuticals for sharing reagents. E.L.V.N. is a Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2172-13). G.W.Y. is an Alfred P. Sloan Research Fellow. G.A.P. is supported by the National Science Foundation Graduate Research Fellowship. Author Contributions: E.L.V.N., A.A.S., M.G., and G.W.Y. conceived the study. E.L.V.N., A.A.S., and C.S. developed the eCLIP methodology. E.L.V.N., C.G.-B., and S.M.B. performed 293T eCLIP and RBFOX2 knockdown experiments. F.R. provided antisense oligonucleotides (ASOs) and M.Y.F. performed ASO experiments. C.G.-B., B.S., S.M.B., T.B.N., K.E., and R.S. performed K562 and HepG2 eCLIP experiments. E.L.V.N. and G.A.P. performed computational analyses. E.L.V.N. and G.W.Y. wrote the manuscript. Code availability. Custom code used is available at https://github.com/gpratt/gatk/releases/tag/2.3.2, and described in Supplementary Protocol 2. Accession codes. All 293T data sets (including SLBP and RBFOX2 eCLIP, RBFOX2 iCLIP, and microarrays profiling RBFOX2 knockdown) have been deposited at the Gene Expression Omnibus (GSE77634). K562 and HepG2 eCLIP data sets have been deposited for public release at the ENCODE Data Coordination Center (https://www.encodeproject.org), with accession identifiers listed in Supplementary Table 2. Competing financial interests: F.R. is a paid employee of Ionis Pharmaceuticals.Attached Files
Accepted Version - nihms765516.pdf
Supplemental Material - nmeth.3810-S1.pdf
Supplemental Material - nmeth.3810-S2.xlsx
Supplemental Material - nmeth.3810-S3.xlsx
Supplemental Material - nmeth.3810-SF1.jpg
Supplemental Material - nmeth.3810-SF10.jpg
Supplemental Material - nmeth.3810-SF11.jpg
Supplemental Material - nmeth.3810-SF12.jpg
Supplemental Material - nmeth.3810-SF13.jpg
Supplemental Material - nmeth.3810-SF14.jpg
Supplemental Material - nmeth.3810-SF15.jpg
Supplemental Material - nmeth.3810-SF2.jpg
Supplemental Material - nmeth.3810-SF3.jpg
Supplemental Material - nmeth.3810-SF4.jpg
Supplemental Material - nmeth.3810-SF5.jpg
Supplemental Material - nmeth.3810-SF6.jpg
Supplemental Material - nmeth.3810-SF7.jpg
Supplemental Material - nmeth.3810-SF8.jpg
Supplemental Material - nmeth.3810-SF9.jpg
Files
Name | Size | Download all |
---|---|---|
md5:302315806d82c102b78e47088c795b7d
|
44.3 kB | Preview Download |
md5:40f38f44293924b2464a230289b9895b
|
199.1 kB | Preview Download |
md5:748e0c235adb0e0c903e18e01212ca39
|
203.0 kB | Preview Download |
md5:e9dbc8e0a71cb901f34b3574dd5dc75f
|
176.5 kB | Preview Download |
md5:70e100398d3b3298a5818b9db431a176
|
223.0 kB | Preview Download |
md5:63baa3bbf7403990a644b694ec290734
|
1.4 MB | Preview Download |
md5:7a0d3b55046ca76c8d6206a611ba1d4d
|
171.7 kB | Preview Download |
md5:474f487d69ad55c1d61574226c881927
|
243.8 kB | Preview Download |
md5:66e797e7eb4255dac2b4ebe9d579012b
|
225.6 kB | Preview Download |
md5:711dd9651d5fc08bf5b7224218ae72e5
|
194.3 kB | Preview Download |
md5:75ada1f6a2a27fb8eb1c94eacce5a9f8
|
185.1 kB | Preview Download |
md5:9b16ccc21f6f8ee7ceed70e24c01d32f
|
88.7 kB | Preview Download |
md5:6319321ed560b16bdaf20f0ecabafcd5
|
155.0 kB | Preview Download |
md5:420c13894beb0e9da8ecc5d62b67633a
|
222.1 kB | Preview Download |
md5:aefcabab0ebfe944f5e183cd8233844b
|
157.1 kB | Preview Download |
md5:cd4b6b75cc76757837ab2542165fe1d3
|
210.5 kB | Preview Download |
md5:8362cfe304bcf7278e3950b20b59e3cd
|
15.9 MB | Preview Download |
md5:a74ec7e5170ce02cdba6f1514309498d
|
35.1 kB | Download |
md5:e8be636b30313323c7420ce9e8e80dd0
|
27.3 kB | Download |
Additional details
- Eprint ID
- 64400
- Resolver ID
- CaltechAUTHORS:20160210-225928240
- NIH
- HG004659
- NIH
- U54HG007005
- NIH
- NS075449
- NIH
- DP5OD012190
- Caltech
- Damon Runyon Cancer Research Foundation
- DRG-2172-13
- Alfred P. Sloan Foundation
- NSF Graduate Research Fellowship
- Created
-
2016-03-31Created from EPrint's datestamp field
- Updated
-
2021-11-10Created from EPrint's last_modified field